| Literature DB >> 25723973 |
Julia Martin1, Lesley MacDonald-Wicks2, Alexis Hure3, Roger Smith4, Clare E Collins5,6.
Abstract
Overweight and obesity is prevalent among women of reproductive age (42% BMI > 25 kg/m2) and parity is associated with risk of weight gain. Weight gain greater than that recommended by the Institute of Medicine (IOM )is also associated with lower rates of breastfeeding initiation and duration in women. The aim of this pilot randomised controlled trial is to examine the feasibility of recruiting and maintaining a cohort of pregnant women with the view of reducing postpartum weight retention and improving breastfeeding outcomes. Women (BMI of 25-35 kg/m2 (n = 36)) were recruited from the John Hunter Hospital antenatal clinic in New South Wales, Australia. Participants were stratified by BMI and randomised to one of three groups with follow-up to six months postpartum. Women received a dietary intervention with or without breastfeeding support from a lactation consultant, or were assigned to a wait-list control group where the dietary intervention was issued at three months postpartum. Feasibility and acceptability was assessed by participation rates and questionnaire. Analysis of variance and covariance was conducted to determine any differences between groups. Sixty-nine per cent of the participants were still enrolled at six months postpartum. This pilot demonstrated some difficulties in recruiting women from antenatal clinics and retaining them in the trial. Although underpowered; the results on weight; biomarkers and breastfeeding outcomes indicated improved metabolic health.Entities:
Mesh:
Year: 2015 PMID: 25723973 PMCID: PMC4377862 DOI: 10.3390/nu7031464
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Flow diagram of recruitment and randomisation for a pilot randomised controlled trial.
Baseline characteristics and birth data for pilot randomised controlled trial participants.
| Participant Characteristic | All ( | Diet ( | Diet + Lactation Support ( | Control ( | |
|---|---|---|---|---|---|
| Age (years) | 30.9 ± 6.0 | 29.5 ± 7.8 | 31.6 ± 5.1 | 31.3 ± 5.6 | 0.27 |
| Height (cm) | 165.4 ± 6.2 | 165.1 ± 6.5 | 166.8 ± 5.7 | 164.4 ± 6.5 | 0.44 |
| Born in Australia, | 33/34 (97) | 10/11 (91) | 11/11 (100) | 12/12 (100) | 0.65 |
| Married or | 25/31 (81) | 7/10 (70) | 8/9 (89) | 10/12 (83) | 0.63 |
| Education ≥ year 12, | 26/31 (84) | 9/10 (90) | 8/9 (89) | 9/12 (75) | 0.79 |
| IRSAD ≥ 5, | 23/32 (72) | 7/10 (70) | 9/10 (90) | 7/12 (58) | 0.22 |
| Smoking, | 4/34 (12) | 2/11 (18) | 1/11 (9) | 1/12 (8) | 1.00 |
| Multiparous, | 5/34 (15) | 1/11 (9) | 2/11 (18) | 2/12 (17) | 0.39 |
| Gestational diabetes, | 3/34 (9) | 2/11 (18) | 1/11 (9) | 0/12 (0) | 0.76 |
| Infant sex, male | 14/33 (42) | 3/11 (27) | 6/10 (60) | 5/12 (42) | 0.23 |
| Birth weight (kg) | 3.7 (3.3, 4.0) | 3.9 (3.7, 4.1) | 3.5 (3.1, 3.7) | 3.5 (3.2, 4.0) | 0.19 |
Mean ± SD for normally distributed continuous data or median (25th–75th percentile) for non-normally distributed data.
Weight data for pilot randomised controlled trial participants.
| Time | Variable | All ( | Diet ( | Diet + Lactation Support ( | Control ( |
|---|---|---|---|---|---|
| Pre-pregnancy | Weight (kg) | 80.5 ± 12.0 | 81.5 ± 15.1 | 81.6 ± 9.8 | 78.5 ± 11.3 |
| BMI (kg/m2) | 28.8 (25.4, 32.3) | 27.7 (25.1, 33.7) | 29.4 (25.5, 32.3) | 28.9 (25.2, 32.9) | |
| Pregnancy | Weight gain (kg) a | 13.6 ± 6.6 | 9.8 ± 4.5 | 15.3 ± 7.2 | 16.0 ± 6.7 |
| Postpartum—3 months | Weight | 84.9 ± 13.7 | 84.2 ± 14.0 | 85.9 ± 14.3 | 84.8 ± 14.3 |
| BMI | 30.8 ± 4.2 | 30.7 ± 4.1 | 30.6 ± 5.4 | 31.1 ± 3.9 | |
| Weight retention (kg) b | 4.6 ± 7.4 | 0.91 ± 7.03 | 4.4 ± 7.6 | 7.7 ± 6.8 | |
| Postpartum—6 months | Weight | 85.3 ± 13.0 | 84.2 ± 14.7 | 89.9 ± 11.3 | 82.7 ± 13.1 |
| BMI | 30.7 ± 3.7 | 30.6 ± 4.3 | 31.2 ± 4.4 | 30.3 ± 3.0 | |
| Weight retention | 3.3 ± 4.0 | 0.8 ± 7.2 | 5.6 ± 8.8 | 5.9 ± 4.9 | |
| Weight ≤ pre-pregnancy, | 5/25 (20) | 3/9 (33) | 2/7 (29) | 1/9 (11) | |
| Weight retention ≥ 5 kg, | 10/25 (40) | 1/9 (11) | 4/7 (57) | 5/9 (56) |
Mean ± SD for normally distributed continuous data or median (25th–75th percentile) for non-normally distributed data. There were no significant differences found between study groups. a Weight gain = Weight measured at 35 weeks gestation—self-reported pre-pregnancy weight; b Weight retention = Weight at visit—self-reported pre-pregnancy weight.
Fasting biochemical data for pilot randomised controlled trial participants.
| Time | Variable | All ( | Diet ( | Diet + Lactation Support ( | Control ( | |
|---|---|---|---|---|---|---|
| Pregnancy | Glucose (mmol/L) | 4.2 ± 0.4 | 4.3 ± 0.5 | 4.2 ± 0.4 | 4.2 ± 0.2 | 0.99 |
| Insulin (mIU/L) | 9.1 ± 3.6 | 8.3 ± 3.0 | 8.8 ± 4.4 | 10.1 ± 3.4 | 0.46 | |
| HbA1c (%) | 5.3 (5.2, 5.5) | 5.3 (5.1, 5.5) | 5.3 (5.1, 5.5) | 5.4 (5.2, 5.6) | 0.48 | |
| HOMA-IR a | 1.7 ± 0.8 | 1.6 ± 0.7 | 1.7 ± 0.9 | 1.9 ± 0.7 | 0.62 | |
| Total cholesterol (mmol/L) | 6.8 ± 1.2 | 6.7 ± 1.0 | 6.6 ± 1.2 | 7.1 ± 1.4 | 0.77 | |
| Triglycerides (mmol/L) | 2.3 ± 0.7 | 2.0 ± 0.4 | 2.3 ± 0.8 | 2.6 ± 0.7 | 0.11 | |
| LDL-C (mmol/L) | 3.9 ± 1.1 | 4.0 ± 0.7 | 3.6 ± 1.1 | 4.1 ± 1.3 | 0.56 | |
| HDL-C (mmol/L) | 1.9 ± 0.5 | 1.9 ± 0.6 | 1.9 ± 0.5 | 1.9 ± 0.4 | 0.95 | |
| Total/HDL-C | 3.8 ± 0.8 | 3.7 ± 0.8 | 3.7 ± 1.0 | 3.9 ± 0.7 | 0.78 | |
| CRP (mg/L) | 7.3 (4.8, 12.9) | 11.1 (6.3, 13.7) | 6.7 (3.0, 14.6) | 7.3 (5.2, 9.5) | 0.91 | |
| Postpartum—3 months | Glucose | 4.6 ± 0.5 | 4.5 ± 0.5 | 4.4 ± 0.4 | 4.7 ± 0.5 | 0.58 |
| Insulin | 5.5 (3.3, 6.8) | 5.2 (4.6, 10.3) | 5.5 (3.2, 6.4) | 5.4 (3.2, 6.8) | 0.61 | |
| HbA1c | 5.3 ± 0.2 | 5.3 ± 0.2 | 5.3 ± 0.2 | 5.5 ± 0.4 | 0.39 | |
| HOMA-IR | 1.0 (0.7, 1.4) | 1.0 (0.8, 2.2) | 1.2 (0.6, 1.4) | 1.1 (0.6, 1.4) | 0.69 | |
| Total cholesterol | 5.0 ± 1.0 | 5.2 ± 1.3 | 4.4 ± 0.6 | 5.2 ± 0.7 | 0.31 | |
| Triglycerides | 1.0 ± 0.6 | 1.2 ± 0.8 | 0.7 ± 0.2 | 1.0 ± 0.6 | 0.25 | |
| LDL-C | 3.0 ± 0.7 | 2.9 ± 0.7 | 2.6 ± 0.6 | 3.1 ± 0.7 | 0.36 | |
| HDL-C | 1.6 ± 0.5 | 1.7 ± 0.7 | 1.5 ± 0.3 | 1.6 ± 0.4 | 0.84 | |
| Total/HDL-C | 3.4 (2.5, 3.6) | 3.5 (2.7, 3.8) | 3.0 (2.9, 3.4) | 3.4 (2.5, 4.4) | 0.61 | |
| CRP | 6.2 ± 4.9 | 7.8 ± 6.4 | 5.6 ± 3.5 | 5.3 ± 4.1 | 0.56 | |
| Postpartum—6 months | Glucose | 4.5 ± 0.4 | 4.5 ± 0.5 | 4.5 ± 0.4 | 4.6 ± 0.4 | 0.91 |
| Insulin | 5.4 (3.2, 6.1) | 5.8 (4.5, 10.2) | 3.5 (2.7, 9.3) | 5.4 (2.9, 6.0) | 0.55 | |
| HbA1c | 5.3 ± 0.3 | 5.3 ± 0.4 | 5.3 ± 0.2 | 5.3 ± 0.3 | 0.88 | |
| HOMA-IR | 1.1 (0.6, 1.4) | 1.1 (0.87, 1.83) | 0.7 (0.5, 2.0) | 1.0 (0.6, 1.3) | 0.65 | |
| Total cholesterol | 4.8 ± 1.2 | 4.7 ± 1.6 | 4.8 ± 1.0 | 4.9 ± 1.0 | 0.95 | |
| Triglycerides | 0.9 (0.5, 1.2) | 1.0 (0.5, 1.4) | 0.8 (0.7, 1.1) | 0.9 (0.5, 1.4) | 0.70 | |
| LDL-C | 2.9 ± 1.0 | 2.7 ± 1.0 | 3.0 ± 1.2 | 3.0 ± 1.0 | 0.83 | |
| HDL-C | 1.3 (1.1, 1.8) | 1.2 (1.1, 1.9) | 1.3 (1.3, 1.3) | 1.5 (1.1, 1.7) | 0.94 | |
| Total/HDL-C | 3.4 (2.6, 4.3) | 3.4 (2.7, 4.3) | 3.7 (3.0, 4.3) | 3.1 (3.0, 4.4) | 0.92 | |
| CRP | 3.5 (3.0, 6.1) | 3.3 (2.0, 6.1) | 5.2 (2.5, 6.6) | 3.1 (3.0, 4.4) | 0.98 |
Mean ± SD for normally distributed continuous data or median (25th–75th percentile) for non-normally distributed data. a HOMA-IR, Homeostatic Model Assessment of Insulin Resistance: (glucose mmol/L × insulin mIU/L)/22.5.